跳至主要内容
临床试验/EUCTR2013-004295-35-AT
EUCTR2013-004295-35-AT进行中(未招募)1 期

ung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalation in cystic fibrosis patients with near normal spirometry - an observational proof-of concept study - LCI-OUT

Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)0 个研究点目标入组 15 人开始时间: 2014年4月2日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - patients suffering from cystic fibrosis
  • - age >= 12 years
  • - chronic P. aeruginosa lung infection
  • - clinically stable at outpatient visit
  • - FEV1 >= 75 % of predicted previous antibiotic aerosol treatment
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 15
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - patients with CF related liver disease or renal disease
  • - pregnant and nursing women

研究者

发起方
Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)

相似试验